| 摘要 |
The invention concerns pharmaceutically useful compounds of formula (I), in which Q, Rm and Rn have the various meanings defined herein, and their non-toxic salts and metabolically labile esters, and pharmaceutical compositions containing them. The novel compounds are of value in treating such conditions such as hypertension and congestive heart failure. The invention further concerns processes for the manufacture of the novel compounds and the use of the compounds in medical treatment. In formula (I), Q is selected from a group of the partial structural formula (IIa, IIb, IIc, IId, or IIe). |
